METTL3 Antibody

Skip to product information
1 of 3

Selleck Chemicals

SKU:F1000-20UL

Regular price €149,00 EUR
Regular price Sale price €149,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

N6-methyladenosine (m6A) is the most abundant mRNA modification, catalyzed by the methyltransferase complex with METTL3 as the sole catalytic subunit. METTL3, a nuclear protein with oncogenic properties, plays key roles in various cancers, dependent or independent of its m6A RNA methyltransferase activity. The 580-amino acid METTL3 contains a zinc finger domain (ZFD) and a methyltransferase domain, both essential for enzymatic activity.

Reported cellular context includes nucleus and cytoplasm, which can matter when signal is compared across treatments or changing cell states. Following METTL3 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

METTL3 is commonly interpreted in the context of cancer research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans nucleus and cytoplasm, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between nucleus and cytoplasm across matched conditions
  • changes associated with proliferative state, oncogenic signaling, or treatment response
  • co-patterning with orthogonal markers and control conditions that clarify pathway state
  • time-matched comparisons so changes reflect biology rather than handling or sampling drift

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for METTL3. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in METTL3 reflect biology rather than handling. When interpreting METTL3, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep METTL3 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
METTL3
Research Area:
Cancer
Application:
FCM • IF • IHC • IP • WB
Reactivity:
Bovine • Cat • Dog • Goat • Guinea Pig • Horse • Human • Mouse • Pig • Primate • Rat • Sheep
Specificity:
METTL3 Antibody [B7E5] detects endogenous levels of total METTL3 protein.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
B7E5
UniProt:
Q86U44
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.